ES2072346T3 - Peptidos sinteticos de la cubierta del htlv-i. - Google Patents

Peptidos sinteticos de la cubierta del htlv-i.

Info

Publication number
ES2072346T3
ES2072346T3 ES90119560T ES90119560T ES2072346T3 ES 2072346 T3 ES2072346 T3 ES 2072346T3 ES 90119560 T ES90119560 T ES 90119560T ES 90119560 T ES90119560 T ES 90119560T ES 2072346 T3 ES2072346 T3 ES 2072346T3
Authority
ES
Spain
Prior art keywords
htlv
cover
hltv
synthetic peptides
env
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90119560T
Other languages
English (en)
Inventor
Deborah Anne Buonagurio
Mathew Longiaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2072346T3 publication Critical patent/ES2072346T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE TRATA DE UN GEN SINTETICO QUE CODIFICA POR LO MENOS UN EPITOPE DE LA REGION CONSERVADA INMUNODOMINANTE DEL HLTV-I ENV GP 21 ASI COMO GENES HIDRIDOS QUE UTILIZAN EL GEN SINTETICO JUNTO CON OTROS EPITOPES DEL HLTV-I ENV GP 46 Y GP 21. SE REVELAN LOS PRODUCTOS DEL GEN CORRESPONDIENTES , LOS VECTORES RECOMBINANTES QUE CONTIENEN LOS GENES, LOS METODOS PARA PRODUCIR LOS POLIPEPTIDES Y LOS METODOS PARA DETECTAR ANTICUERPOS DEL HLTV-I UTILIZANDO LOS POLIPEPTIDES DE LA INVENCION.
ES90119560T 1989-10-23 1990-10-12 Peptidos sinteticos de la cubierta del htlv-i. Expired - Lifetime ES2072346T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42525289A 1989-10-23 1989-10-23

Publications (1)

Publication Number Publication Date
ES2072346T3 true ES2072346T3 (es) 1995-07-16

Family

ID=23685787

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90119560T Expired - Lifetime ES2072346T3 (es) 1989-10-23 1990-10-12 Peptidos sinteticos de la cubierta del htlv-i.

Country Status (8)

Country Link
US (2) US5693755A (es)
EP (1) EP0424748B1 (es)
JP (1) JP2637278B2 (es)
AU (1) AU643710B2 (es)
CA (1) CA2028172A1 (es)
DE (1) DE69019291T2 (es)
ES (1) ES2072346T3 (es)
NZ (1) NZ235764A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
AU7258491A (en) * 1990-02-09 1991-09-03 E.I. Du Pont De Nemours And Company Htlv envelope antigenic segment
WO1992004046A1 (en) * 1990-08-29 1992-03-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce Novel peptide antigens and immunoassays, test kits and vaccines using the same
AU2412692A (en) * 1991-07-23 1993-02-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel peptide antigens and immunoassays, test kits and vaccines using the same
AU2487300A (en) * 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
ES2299276T3 (es) * 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
WO2000039302A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP2292772A1 (en) * 2001-07-05 2011-03-09 Novartis Vaccines and Diagnostics, Inc. HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
CA2458995C (en) * 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) * 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US20040096826A1 (en) * 2002-01-30 2004-05-20 Evans Glen A. Methods for creating recombination products between nucleotide sequences
TW200409815A (en) 2002-12-12 2004-06-16 Dev Center Biotechnology Human T-lymphotrophic virus (HTLV) fusion protein, nucleic acid and vector encoding the protein, and kit for testing human T-lymphotrophic virus using the protein
EP1477495B1 (en) * 2003-04-25 2007-04-04 Development Center For Biotechnology Antigenic fragments of the gp21 envelope protein of human T-Lymphotropic virus HTLV
US8293101B2 (en) 2009-03-13 2012-10-23 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
WO2018116074A1 (en) * 2016-12-19 2018-06-28 Kabiri Mona Chimeric peptides against htlv-1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724258A (en) * 1984-02-03 1988-02-09 Juridical Foundation, Japanese Foundation For Cancer Research Adult T cell leukemia virus antigen polypeptide
NZ213823A (en) * 1984-10-26 1988-05-30 Us Health Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria
JP2564268B2 (ja) * 1985-08-28 1996-12-18 協和醗酵工業株式会社 融合抗原ポリペプチド
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
US5003043A (en) * 1988-05-25 1991-03-26 Triton Biosciences Inc. Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
AU5827590A (en) * 1989-06-01 1991-01-07 E.I. Du Pont De Nemours And Company Htlv-1 env gene products expressed in (e. coli)

Also Published As

Publication number Publication date
CA2028172A1 (en) 1991-04-24
DE69019291D1 (de) 1995-06-14
EP0424748A1 (en) 1991-05-02
JPH03232491A (ja) 1991-10-16
AU643710B2 (en) 1993-11-25
NZ235764A (en) 1993-01-27
AU6489290A (en) 1991-04-26
US5837818A (en) 1998-11-17
JP2637278B2 (ja) 1997-08-06
US5693755A (en) 1997-12-02
EP0424748B1 (en) 1995-05-10
DE69019291T2 (de) 1995-09-21

Similar Documents

Publication Publication Date Title
ES2072346T3 (es) Peptidos sinteticos de la cubierta del htlv-i.
ES2173082T3 (es) Vectores retrovirales que contienen sitios de entrada del ribosoma internos.
AR245684A1 (es) Procedimiento mejorado de hidrogenolisis/deshidrohalogenacion
SG52589A1 (en) Antigenic epitopes presend on membrane-bound but not secreted iga
ES2032016T3 (es) Un procedimiento para la produccion de las 13, 14-ceto-pgfs.
WO1989007136A3 (en) Modified hepatocytes and uses therefor
FI925043A0 (fi) Varianta cd44-ytproteiner, dna-sekvenser som kodar foer dem, antikroppar mot dessa proteiner samt deras anvaendning i diagnos och terapi
CO5560591A2 (es) Vacunas de adn optimizadas por el codon vih-gag
ATE136908T1 (de) Peptide und antikörper, die die integrin- ligandbindung inhibieren
ES2161682T3 (es) Peptidos especificos a hcv, agentes adecuados para ellos y su utilizacion.
ES2129836T3 (es) Componentes y catalizadores para la polimerizacion de olefinas.
ATE274578T1 (de) Von menschlichen t-zellen immunodominante epitopen des virus der c-hepatitis
DK366483D0 (da) Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmade til fremstilling af samme samt fremgangsmade til fremstilling af human preprorelaxin eller en underenhed deraf
CY1109699T1 (el) Νουκλεινικα οξεα που κωδικοποιουν πολυπεπτιδια πολυεπιτοπων
ES440214A1 (es) Un procedimiento de sintesis de calcitonina de salmon.
NZ219113A (en) Hiv peptide containing epitope of the env protein
EP0345462A3 (en) Immunoassay for hiv-1 antigens using f(ab')2 fragments as probe
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DK0470980T3 (da) Syntetiske peptider til en HIV-1-vaccine
ES2090324T3 (es) Vacuna anticoccidica recombinante.
ES2069742T3 (es) Proteina de la capsida del calicivirus felino y secuencia nucleotida.
ATE420183T1 (de) Antigen-konstrukte, für den nachweis und die unterscheidung von antikörpern gegen hiv
ES2168253T3 (es) Peptidos especificos para hcmv y su utilizacion.
ES2123949T3 (es) Procedimiento para la preparacion de intermediarios para la sintesis de agentes antifungicos.
ES2061719T3 (es) Proceso para la produccion de proteinas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 424748

Country of ref document: ES